91 related articles for article (PubMed ID: 11243118)
1. [Protein tyrosine kinase (PTK) activities during the induction of apoptosis by arsenic trioxide (As2O3)].
Xiao D; Sun G; Wu W
Zhonghua Xue Ye Xue Za Zhi; 1998 May; 19(5):234-6. PubMed ID: 11243118
[TBL] [Abstract][Full Text] [Related]
2. [Effects of As2O3 on the BCR/ABL protein tyrosine phosphorylation in K562 cells].
Xiao D; Sun G; Su H
Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):637-9. PubMed ID: 11721366
[TBL] [Abstract][Full Text] [Related]
3. [Arsenic trioxide inhibits cell growth in imatinib-resistant bcr-abl mutant cell lines in vitro].
Lu RZ; Qiu L; Wang XD; Li XF; Chen LJ; Wang XL; Zhang BL; Ma J
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):13-7. PubMed ID: 19563028
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide and bortezomib interact synergistically to induce apoptosis in chronic myelogenous leukemia cells resistant to imatinib mesylate through Bcr/Abl‑dependent mechanisms.
Xu W; Wei W; Yu Q; Wu C; Ye C; Wu Y; Yan H
Mol Med Rep; 2014 Sep; 10(3):1519-24. PubMed ID: 24939418
[TBL] [Abstract][Full Text] [Related]
5. BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity.
Puccetti E; Güller S; Orleth A; Brüggenolte N; Hoelzer D; Ottmann OG; Ruthardt M
Cancer Res; 2000 Jul; 60(13):3409-13. PubMed ID: 10910048
[TBL] [Abstract][Full Text] [Related]
6. [Effects of protein tyrosine kinase, protein tyrosine phosphatase and protein kinase C on the apoptosis of arsenic trioxide treated NB4 cells and human cortex neurons].
Zhou J; Meng R; Sui XH; Lu M; Wang DS; Yang BF
Zhonghua Xue Ye Xue Za Zhi; 2004 Oct; 25(10):600-4. PubMed ID: 15634593
[TBL] [Abstract][Full Text] [Related]
7. Leukemia-associated translocation products able to activate RAS modify PML and render cells sensitive to arsenic-induced apoptosis.
Puccetti E; Beissert T; Güller S; Li JE; Hoelzer D; Ottmann OG; Ruthardt M
Oncogene; 2003 Oct; 22(44):6900-8. PubMed ID: 14534537
[TBL] [Abstract][Full Text] [Related]
8. Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Brc-Abl-positive acute leukemia cells.
Porosnicu M; Nimmanapalli R; Nguyen D; Worthington E; Perkins C; Bhalla KN
Leukemia; 2001 May; 15(5):772-8. PubMed ID: 11368438
[TBL] [Abstract][Full Text] [Related]
9. Targeting catalase but not peroxiredoxins enhances arsenic trioxide-induced apoptosis in K562 cells.
Song LL; Tu YY; Xia L; Wang WW; Wei W; Ma CM; Wen DH; Lei H; Xu HZ; Wu YL
PLoS One; 2014; 9(8):e104985. PubMed ID: 25115845
[TBL] [Abstract][Full Text] [Related]
10. Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cells.
Yoon P; Giafis N; Smith J; Mears H; Katsoulidis E; Sassano A; Altman J; Redig AJ; Tallman MS; Platanias LC
Mol Cancer Ther; 2006 Nov; 5(11):2815-23. PubMed ID: 17121928
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.
Wetzler M; Brady MT; Tracy E; Li ZR; Donohue KA; O'Loughlin KL; Cheng Y; Mortazavi A; McDonald AA; Kunapuli P; Wallace PK; Baer MR; Cowell JK; Baumann H
Clin Cancer Res; 2006 Nov; 12(22):6817-25. PubMed ID: 17121903
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic effect of As2S2 on K562 cells and its mechanism.
Li JE; Wu WL; Wang ZY; Sun GL
Acta Pharmacol Sin; 2002 Nov; 23(11):991-6. PubMed ID: 12421474
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
14. Effects of As(2)O(3) on BCR-ABL protein level and signal transduction in CML cells.
Lai Z; Sun G; Wu W; Wu Y
Zhonghua Xue Ye Xue Za Zhi; 2002 Jul; 23(7):360-2. PubMed ID: 12411053
[TBL] [Abstract][Full Text] [Related]
15. Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide.
Goussetis DJ; Gounaris E; Wu EJ; Vakana E; Sharma B; Bogyo M; Altman JK; Platanias LC
Blood; 2012 Oct; 120(17):3555-62. PubMed ID: 22898604
[TBL] [Abstract][Full Text] [Related]
16. [The mechanism of arsenic trioxide-inducing apoptosis of K562 cells].
Zhang XH; Zhang R; Zhu ZL; Wang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):558-62. PubMed ID: 15498110
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells.
Li H; Wang Y; Xu W; Dong L; Guo Y; Bi K; Zhu C
Acta Haematol; 2015; 133(1):18-25. PubMed ID: 24993472
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
[TBL] [Abstract][Full Text] [Related]
19. [Effects of anti-ABL tyrosine kinase intrabody on the growth of K562 cells in nude mice].
Xu D; Song JM; Hu Y; Guo H; Cao DJ; Wang P; Liu H; Zhao CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):11-4. PubMed ID: 12905832
[TBL] [Abstract][Full Text] [Related]
20. BCR-ABL/p62/SQSTM1: a cannibal embrace.
Auberger P
Blood; 2012 Oct; 120(17):3389-90. PubMed ID: 23100300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
